Schizophrenia Research

A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study.  238:128-136. 2021

Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.  228:60-73. 2021

Markers of copper transport in the cingulum bundle in schizophrenia.  228:124-133. 2021

Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies.  223:29-42. 2020

Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis.  220:164-171. 2020

Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia.  218:233-239. 2020

AMPA receptor subunit localization in schizophrenia anterior cingulate cortex 2020

The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies 2020

Ultrastructural evidence for glutamatergic dysregulation in schizophrenia 2020

A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.  210:239-244. 2019

The transcriptome landscape associated with Disrupted-in-Schizophrenia-1 locus impairment in early development and adulthood.  210:149-156. 2019

N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study.  208:479-480. 2019

Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.  204:262-270. 2019

Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia.  204:104-110. 2019

Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial.  203:24-31. 2019

Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia.  197:484-491. 2018

Substantia nigra ultrastructural pathology in schizophrenia.  197:209-218. 2018

Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances.  197:492-497. 2018

The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study.  195:572-573. 2018

Linking optic radiation volume to visual perception in schizophrenia and bipolar disorder.  190:102-106. 2017

Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.  182:66-73. 2017

Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.  177:78-87. 2016

Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing.  176:467-472. 2016

Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia.  174:189-191. 2016

Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia.  172:137-142. 2016

A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.  170:341-350. 2016

Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.  169:369-373. 2015

Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.  168:543-553. 2015

The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study.  165:171-174. 2015

UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment.  164:187-192. 2015

Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.  166:219-224. 2015

Factor structure and heritability of endophenotypes in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS-1).  163:73-79. 2015

Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study: The moderating role of smoking status and antipsychotic medications.  163:24-31. 2015

Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8years later.  161:407-413. 2015

Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia.  159:130-135. 2014

The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.  159:95-100. 2014

Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.  154:1-13. 2014

Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia.  154:36-41. 2014

Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.  157:33-39. 2014

Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex.  152:111-116. 2014

Neurocognition and symptoms identify links between facial recognition and emotion processing in schizophrenia: Meta-analytic findings.  151:78-84. 2013

Effects of single dose intranasal oxytocin on social cognition in schizophrenia.  147:393-397. 2013

Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.  147:348-354. 2013

Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia.  147:32-38. 2013

Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia.  146:177-183. 2013

Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.  144:1-8. 2013

Cognitive training at home in schizophrenia is feasible.  143:397-398. 2013

Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.  140:136-142. 2012

Factor structure of emotional intelligence in schizophrenia.  139:78-81. 2012

Heritability of functioning in families with schizophrenia in relation to neurocognition.  139:105-109. 2012

Regional differences in expression of β-tubulin isoforms in schizophrenia.  135:181-186. 2012

Remission and recovery during the first outpatient year of the early course of schizophrenia.  132:18-23. 2011

Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.  131:52-57. 2011

Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.  130:260-265. 2011

Do patients with schizophrenia benefit from a self-referential memory bias?.  127:171-177. 2011

Relationships between perceptions of the family environment and of negative life events in recent-onset schizophrenia patients.  127:266-267. 2011

Disorganization and reality distortion in schizophrenia: A meta-analysis of the relationship between positive symptoms and neurocognitive deficits.  121:1-14. 2010

Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.  119:198-209. 2010

Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.  117:92-98. 2010

Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.  114:50-56. 2009

Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis.  113:189-199. 2009

Linkage analysis of schizophrenia in African-American families.  109:70-79. 2009

Emotional intelligence in schizophrenia.  107:61-68. 2009

Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.  104:108-120. 2008

Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.  103:71-82. 2008

Stability of visual masking performance in recent-onset schizophrenia: An 18-month longitudinal study.  103:266-274. 2008

Diffusion tensor imaging in schizophrenia: Relationship to symptoms.  98:157-162. 2008

Visual self-recognition in patients with schizophrenia.  94:215-220. 2007

Disruption of hippocampal connectivity in children and adolescents with schizophrenia - A voxel-based diffusion tensor imaging study.  90:302-307. 2007

Erratum to "Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods" [Schizophrenia Research 87 (1-3) (2006) 32-44] (DOI:10.1016/j.schres.2006.06.027).  90:369. 2007

Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.  90:15-27. 2007

Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.  86:167-171. 2006

The role of stimulus salience in CPT-AX performance of schizophrenia patients.  81:191-197. 2006

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods.  87:32-44. 2006

Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.  78:87-93. 2005

Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia.  75:27-34. 2005

NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder.  71:361-370. 2004

Thalamic dysfunction in schizophrenia: Neurochemical, neuropathological, and in vivo imaging abnormalities.  69:237-253. 2004

Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia.  68:65-73. 2004

Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia.  62:213-224. 2003

Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain.  38:7-12. 1999

Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.  33:113-118. 1998

The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia.  31:141-150. 1998

Clozapine-reserpine combination for refractory psychosis.  25:259-260. 1997

Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature.  22:133-141. 1996